Inactive Instrument

Exactus Inc Stock OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Nov. 18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Maximize my profits

Market Cap	519K 454K 417K 389K 737K 49.41M 748K 5.01M 1.95M 24.29M 1.95M 1.91M 83.7M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.27M 17.71M 16.51M 31.32M 2.1B 31.79M 213M 82.67M 1.03B 82.76M 80.98M 3.56B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

Nov. 18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-31	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
23-11-14	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-10-04	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
23-10-01	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
23-09-29	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
23-08-15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-01	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
23-06-15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

Nov. 18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
24-05-16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
24-05-16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
23-10-05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
23-10-02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+1.86%	+0.48%	+55.50%	+163.08%	1,082B
JOHNSON & JOHNSON	+3.57%	+3.29%	+68.60%	+61.03%	633B
ABBVIE INC.	+3.99%	+3.05%	+37.93%	+93.37%	461B
ROCHE HOLDING AG	+3.86%	+1.64%	+32.57%	+24.89%	338B
ASTRAZENECA PLC	-0.56%	+0.96%	+41.67%	+39.35%	299B
NOVARTIS AG	-0.08%	+1.30%	+32.15%	+44.48%	291B
NOVO NORDISK A/S	-1.54%	+2.81%	-25.35%	-39.61%	222B
AMGEN INC.	+3.55%	+4.41%	+25.45%	+66.28%	202B
GILEAD SCIENCES, INC.	+4.21%	+2.65%	+17.47%	+71.11%	163B
Average	+2.10%	+4.58%	+31.78%	+58.22%	410.27B
Weighted average by Cap.	+2.25%	+5.53%	+42.31%	+83.31%

	2022	2023
Net sales	1.63M 1.42M 1.31M 1.22M 2.31M 155M 2.35M 15.69M 6.1M 76.15M 6.11M 5.98M 262M	2.38M 2.08M 1.92M 1.79M 3.39M 227M 3.44M 23M 8.94M 112M 8.95M 8.76M 385M
Net income	-9.14M -7.99M -7.35M -6.85M -12.99M -871M -13.18M -88.18M -34.28M -428M -34.32M -33.58M -1.47B	-8.02M -7.01M -6.44M -6M -11.38M -763M -11.56M -77.31M -30.05M -375M -30.09M -29.44M -1.29B
Net Debt	17.85M 15.61M 14.34M 13.37M 25.36M 1.7B 25.74M 172M 66.94M 836M 67.02M 65.58M 2.88B	21.53M 18.82M 17.3M 16.12M 30.58M 2.05B 31.04M 208M 80.72M 1.01B 80.81M 79.08M 3.47B

Exactus Inc Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile